45 CFR 46 Subpart C: Prisoner Research Rules and IRB Findings

45 CFR 46 Subpart C sets the federal rules that apply when biomedical or behavioral research involving prisoners is conducted or supported by the U.S. Department of Health and Human Services. It restricts prisoner research to four permitted categories, requires an Institutional Review Board (IRB) to make seven specific findings before approval, imposes special composition rules on that IRB, and prohibits enrollment until the Office for Human Research Protections (OHRP) issues an authorization letter.

When Subpart C Applies

Subpart C governs all biomedical and behavioral research involving prisoners that is conducted or supported by HHS. A privately funded study receiving no HHS support is not bound by Subpart C as a matter of federal law, though many institutions apply the standards voluntarily and state or local law may add its own restrictions. Nothing in Subpart C overrides a stricter state prohibition on prisoner research.1eCFR. 45 CFR 46.301 – Applicability

Institutions holding an active Federalwide Assurance with OHRP have committed to the Common Rule, and prisoner protections often get pulled in through that commitment even where they would not otherwise apply.

Who Counts as a Prisoner

Under 45 CFR 46.303(c), a prisoner is any individual involuntarily confined or detained in a penal institution. The definition reaches beyond traditional prison walls. It covers people held in local jails and federal or state prisons, people detained pending arraignment, trial, or sentencing, and people confined under statutes or commitment procedures that serve as alternatives to criminal prosecution or standard incarceration.2eCFR. 45 CFR 46.303 – Definitions

Someone court-ordered into a residential treatment program in place of prosecution would likely qualify. The regulation does not name halfway houses or probation, and where a case is ambiguous the safer path is to treat the person as covered.

The Four Permitted Categories of Research

Under 45 CFR 46.306, the Secretary of HHS will approve prisoner research only if it falls into one of four categories. The first two carry a strict ceiling: no more than minimal risk and no more than inconvenience to participants.

  • Category 1: Studies examining possible causes, effects, and processes of incarceration or criminal behavior.
  • Category 2: Studies of prisons as institutions or of prisoners as incarcerated people.
  • Category 3: Research on conditions that disproportionately affect prisoners as a group, such as hepatitis vaccine trials, substance use disorder research, and studies of sexual assault in correctional settings.
  • Category 4: Research on practices, whether new or established, that are intended to and have a reasonable probability of improving the health or well-being of the individual participants.

Categories 3 and 4 can involve more than minimal risk but trigger extra oversight. For Category 3, the Secretary must consult with experts in penology, medicine, and ethics and publish a notice in the Federal Register before the study proceeds. For Category 4, that same consultation and publication requirement applies only when the design assigns prisoners to control groups that may not benefit from the research.3eCFR. 45 CFR 46.306 – Permitted Research Involving Prisoners

Minimal risk in this context means the probability and magnitude of harm normally encountered in the daily lives, or in routine medical, dental, or psychological examinations, of healthy people. The standard references healthy people generally, not the heightened risks of prison life, so a study cannot justify greater risk by pointing to how dangerous incarceration already is.2eCFR. 45 CFR 46.303 – Definitions

The Seven Required IRB Findings

Before approving prisoner research, the IRB must make seven specific findings under 45 CFR 46.305. These go beyond ordinary IRB review and address the coercion risks unique to incarceration.

  • The research fits one of the permitted categories.
  • Any advantages of participating (better food, improved living conditions, extra money) are not so great, when weighed against the deprivations of prison life, that a prisoner cannot rationally weigh the risks. Twenty dollars means something very different inside a prison than outside one, and the IRB must judge compensation in context.
  • The risks are comparable to those a non-incarcerated volunteer would accept.
  • Selection of participants is fair to all prisoners and free from interference by staff or other inmates, with control subjects randomly selected from eligible prisoners unless the principal investigator provides written justification for another method.
  • Consent information is written in language the prison population can actually understand.
  • Parole boards will not factor participation into release decisions, and every participant is told upfront that joining or declining has no effect on sentence or parole.
  • Adequate arrangements exist for any medical examination or follow-up care participants may need after the study, taking into account that prisoners serve sentences of varying lengths and may be released at different times.
4eCFR. 45 CFR 46.305 – Additional Duties of the Institutional Review Boards Where Prisoners Are Involved

IRB Composition

Under 45 CFR 46.304, an IRB reviewing prisoner research has two structural requirements on top of standard composition rules. The board must include at least one member who is a prisoner or a prisoner representative with enough background and experience to advocate effectively for incarcerated participants. In practice this is often a former prisoner, a prisoner rights advocate, or someone with professional experience in corrections.

A majority of the remaining members must have no association with the prison where the research will take place, apart from their seat on the board. If more than one IRB reviews a study, only one needs to include the prisoner or prisoner representative.5eCFR. 45 CFR 46.304 – Composition of Institutional Review Boards Where Prisoners Are Involved

The regulation technically permits expedited review, but OHRP recommends that all prisoner research go before a fully convened board. Where expedited review is used, OHRP recommends the reviewer include the prisoner or prisoner representative.6U.S. Department of Health & Human Services. Prisoner Research FAQs

Certification to OHRP and the Authorization Letter

Once the IRB approves the protocol and makes the seven findings, the institution certifies those findings to OHRP. The certification package includes the approved protocol, consent forms, IRB application materials, and other documentation the board considered. Institutions submit these through OHRP’s online submission form.7U.S. Department of Health & Human Services. Subpart C Certification Request to OHRP

No prisoner research may begin until OHRP issues an authorization letter confirming that the study fits a permitted category and that the IRB fulfilled its duties. The regulations set no timeline for this review, so lead time has to be built into the research schedule. Keep the authorization letter as a permanent research record; auditors ask for it first.6U.S. Department of Health & Human Services. Prisoner Research FAQs

When an Enrolled Participant Becomes a Prisoner

If a participant is arrested and jailed after a study has begun, the investigator must promptly notify the IRB. All research interactions, interventions, and collection of identifiable private information about that person must stop immediately.6U.S. Department of Health & Human Services. Prisoner Research FAQs

To keep the participant in the study, the IRB must re-review the entire protocol under Subpart C, and the institution must certify to OHRP and receive an authorization letter before activity resumes. There is one exception. If the investigator determines that staying in the study is in the participant’s best interest, for example when withdrawing from a treatment protocol would cause harm, the participant may continue while Subpart C review catches up. Prompt notification to the IRB is still required.

Some of the seven findings may not translate cleanly to a person recruited as a free volunteer and later jailed. The fair-selection finding, written for studies that recruit inside prisons, is a common example. The IRB should document that the finding is inapplicable rather than force it onto a situation it was not written for.

Boundaries and Narrow Exceptions

A few boundaries are worth stating so nothing gets assumed by default.

Exempt research. Under the 2018 Common Rule, most exempt research categories cannot include prisoners. The one exception is research aimed at a broader population that only incidentally includes prisoners. Any study that deliberately focuses on prisoners loses exemption and falls under the full Subpart C framework.8U.S. Department of Health & Human Services. Unofficial Revised Common Rule Regulatory Text

Epidemiological waiver. In 2003 the Secretary of HHS waived certain Subpart C requirements for narrow epidemiological research. A study qualifies only if its sole purpose is to describe prevalence or incidence of a disease or to study its risk factors. The IRB must still complete a Subpart C review and certify to OHRP that the research is no more than minimal risk, that prisoners are not the particular focus of the study, and that the remaining requirements of 46.305(a)(2) through (7) are met.9Federal Register. Waiver of the Applicability of Certain Provisions of Department of Health and Human Services

FDA-regulated studies. FDA’s parallel prisoner regulations at 21 CFR 50 Subpart C have been stayed indefinitely and are not currently in effect. When a prisoner study is also under FDA jurisdiction, such as a clinical drug trial, 45 CFR 46 Subpart C remains the operative federal framework. As of 2026, no separate FDA prisoner-research requirements apply.

Consequences of Non-Compliance

Enrolling prisoners before OHRP issues its authorization letter, missing an IRB composition requirement, or skipping any of the seven required findings exposes an institution to serious administrative action. OHRP can suspend or terminate IRB approval for a specific protocol or for all research at the institution, restrict new enrollment, disqualify individual investigators, and refer cases to other federal agencies. In severe cases, an institution or investigator can be debarred from receiving federal funds. Documentation, especially the OHRP authorization letter, is the first thing an audit will look for.